- Home
- NDLS vs VNRX Comparison
NDLS vs VNRX Comparison
Compare NDLS & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- VNRX
- Stock Information
- Founded
- NDLS 1995
- VNRX N/A
- Country
- NDLS United States
- VNRX United States
- Employees
- NDLS N/A
- VNRX N/A
- Industry
- NDLS Restaurants
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NDLS Consumer Discretionary
- VNRX Health Care
- Exchange
- NDLS Nasdaq
- VNRX Nasdaq
- Market Cap
- NDLS 45.2M
- VNRX 45.2M
- IPO Year
- NDLS 2013
- VNRX N/A
- Fundamental
- Price
- NDLS $0.90
- VNRX $0.51
- Analyst Decision
- NDLS Strong Buy
- VNRX Strong Buy
- Analyst Count
- NDLS 2
- VNRX 5
- Target Price
- NDLS $3.00
- VNRX $3.75
- AVG Volume (30 Days)
- NDLS 79.4K
- VNRX 172.1K
- Earning Date
- NDLS 05-07-2025
- VNRX 05-20-2025
- Dividend Yield
- NDLS N/A
- VNRX N/A
- EPS Growth
- NDLS N/A
- VNRX N/A
- EPS
- NDLS N/A
- VNRX N/A
- Revenue
- NDLS $495,670,000.00
- VNRX $1,233,511.00
- Revenue This Year
- NDLS $4.57
- VNRX $563.72
- Revenue Next Year
- NDLS $1.29
- VNRX $160.43
- P/E Ratio
- NDLS N/A
- VNRX N/A
- Revenue Growth
- NDLS N/A
- VNRX 59.10
- 52 Week Low
- NDLS $0.55
- VNRX $0.42
- 52 Week High
- NDLS $2.36
- VNRX $0.90
- Technical
- Relative Strength Index (RSI)
- NDLS 38.19
- VNRX 52.65
- Support Level
- NDLS $0.81
- VNRX $0.46
- Resistance Level
- NDLS $1.09
- VNRX $0.54
- Average True Range (ATR)
- NDLS 0.07
- VNRX 0.04
- MACD
- NDLS 0.00
- VNRX 0.01
- Stochastic Oscillator
- NDLS 21.07
- VNRX 67.70
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.